» Articles » PMID: 38455311

A Comparison Between Omicron and Earlier COVID-19 Variants' Disease Severity in the Milan Area, Italy

Overview
Journal Front Epidemiol
Specialty Public Health
Date 2024 Mar 8
PMID 38455311
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the context of the fourth wave of the COVID-19 pandemic in Italy, which occurred in correspondence with the outbreak of the Omicron variant, it became fundamental to assess differences in the risk of severe disease between the Omicron variant and the earlier SARS-CoV-2 variants that were still in circulation despite Omicron becoming prevalent.

Methods: We collected data on 2,267 genotyped PCR-positive swab tests and assessed whether the presence of symptoms, risk of hospitalization, and recovery times were significantly different between Omicron and the earlier variants. Multivariable models adjusted for sex, age class, citizenship, comorbidities, and symptomatology allowed assessing the difference in outcomes between Omicron and the earlier variants according to vaccination status and timing of administration.

Results: Compared to the earlier variants in the same period, Omicron was less symptomatic, resulted in fewer hospital admissions for those who were unvaccinated and for those who were already immunized after the booster dose, and was associated with quicker recovery, yet not in subjects with three vaccination doses.

Conclusion: Despite being milder, Omicron's higher transmissibility and vaccine resistance should not lead to underrating its damage potential, especially with regard to hospital and health service saturation.

Citing Articles

Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia.

Chang J, Grimley S, Tran B, Deliyannis G, Tumpach C, Nguyen A iScience. 2024; 27(6):110009.

PMID: 38868206 PMC: 11166695. DOI: 10.1016/j.isci.2024.110009.


Regional and temporal variations in COVID-19 cases and deaths in Ethiopia: Lessons learned from the COVID-19 enhanced surveillance and response.

Teka G, Woldeab A, Dereje N, Eshetu F, Gizachew L, Tazu Z PLOS Glob Public Health. 2024; 4(5):e0003175.

PMID: 38781131 PMC: 11115226. DOI: 10.1371/journal.pgph.0003175.


Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.

San Martin-Lopez J, Mesa N, Bernal-Bello D, Morales-Ortega A, Rivilla M, Guerrero M Viruses. 2023; 15(9).

PMID: 37766248 PMC: 10538062. DOI: 10.3390/v15091839.


Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review.

Rzymski P, Pokorska-Spiewak M, Jackowska T, Kuchar E, Nitsch-Osuch A, Pawlowska M Vaccines (Basel). 2023; 11(9).

PMID: 37766178 PMC: 10537111. DOI: 10.3390/vaccines11091502.


Comparison of clinical outcomes, demographic, and laboratory characteristics of hospitalized COVID-19 patients during major three waves driven by Alpha, Delta, and Omicron variants in Tehran, Iran.

Heydarifard Z, Shafiei-Jandaghi N, Safaei M, Tavakoli F, Shatizadeh Malekshahi S Influenza Other Respir Viruses. 2023; 17(8):e13184.

PMID: 37565071 PMC: 10410233. DOI: 10.1111/irv.13184.


References
1.
Stefanelli P, Trentini F, Petrone D, Mammone A, Ambrosio L, Manica M . Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022. Euro Surveill. 2022; 27(45). PMC: 9650705. DOI: 10.2807/1560-7917.ES.2022.27.45.2200125. View

2.
Sudre C, Keshet A, Graham M, Joshi A, Shilo S, Rossman H . Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Lancet Digit Health. 2021; 3(9):e577-e586. PMC: 8297994. DOI: 10.1016/S2589-7500(21)00115-1. View

3.
Accorsi E, Britton A, Fleming-Dutra K, Smith Z, Shang N, Derado G . Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. JAMA. 2022; 327(7):639-651. PMC: 8848203. DOI: 10.1001/jama.2022.0470. View

4.
Divino F, Alaimo di Loro P, Farcomeni A, Jona-Lasinio G, Lovison G, Ciccozzi M . Decreased severity of the Omicron variant of concern: further evidence from Italy. Int J Infect Dis. 2022; 119:21-23. PMC: 8935975. DOI: 10.1016/j.ijid.2022.03.023. View

5.
Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B . Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves. JAMA. 2021; 327(6):583-584. PMC: 8719272. DOI: 10.1001/jama.2021.24868. View